Alpha Preclinical (Alpha) formed in 2020 and is a US owned company. We are a discovery preclinical research service company designed to address the rapid and expansive growth demand of the discovery preclinical research sector. The life-science research community is being challenged to accelerate therapies into the market with better operational efficiency. Outsourcing preclinical research needs, allows companies to focus on their core competencies and reduce time to market. Alpha bridges our client's needs to reach the clinic and harnessing our expertise using a personalized interface approach. Our goal is to strategically partner with our clients by reliably providing well-executed and cost-effective studies conducted in a timely manner to support their innovative drug development and research programs.